Notice2021-17678
Notice of Award of a Single-Source Grant To Fund Task Force for Global Health, Inc.
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 18, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS) announces the award of approximately $47,000,000 in COVID-19 funding with an expected total funding of $100,000,000 over a five-year period to the Task Force for Global Health to expand the influenza and COVID-19 vaccine coverage in low- and middle-income countries.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 157 (Wednesday, August 18, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 157 (Wednesday, August 18, 2021)]
[Notices]
[Pages 46257-46258]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-17678]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Grant To Fund Task Force for
Global Health, Inc.
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS) announces the
award of approximately $47,000,000 in COVID-19 funding with an expected
total funding of $100,000,000 over a five-year period to the Task Force
for Global Health to expand the influenza and COVID-19 vaccine coverage
in low- and middle-income countries.
DATES: The period for this award will be September 30, 2021 through
September 29, 2026.
FOR FURTHER INFORMATION CONTACT: Archana Kumar, National Center for
Immunization and Respiratory Diseases, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS-H24-8, Atlanta, GA 30329,
Telephone: 800-232-6348, E-Mail: <a href="/cdn-cgi/l/email-protection#11747e727467747f65252524517275723f767e67"><span class="__cf_email__" data-cfemail="7d18121e180b1813094949483d1e191e531a120b">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The single-source award will introduce and/
or expand influenza vaccine programs, contribute to evidence base for
influenza control and prevention, and leverage efforts to deploy
pandemic vaccines to low- and middle-income countries.
The Task Force for Global Health will be awarded as a single-source
because of their specific experience collaborating with multiple
partners in facilitating the use of influenza vaccines in low- to
middle-income countries and in developing local and global evidence
base for sustained use of lifesaving vaccines since 2014. The Task
Force for Global Health is uniquely qualified to support countries to
plan for, implement and evaluate COVID-19 vaccination programs since
they are currently working with the same risk groups using established
tools and platforms under an existing cooperative agreement. The Task
Force for Global Health leads the Partnership for Influenza Vaccine
Introduction which includes ministries of health from 15 countries,
private industry, and the United Nations International Children's
Emergency Fund. This Partnership creates sustainable, seasonal
influenza vaccination programs in the targeted countries, works with
the World Health Organization to prepare for pandemic influenza, and
supports countries' efforts to control and prevent seasonal outbreaks.
Summary of the Award
Recipient: The Task Force For Global Health.
Purpose of the Award: The purpose of award is to expand the use of
influenza and COVID-19 vaccines in low- and middle-income countries
(LMICs), support influenza vaccine introduction through a public-
private partnership, establish an evidence base for global vaccine
introduction decisions, and leverage this partnership to support
readiness for and deployment of future pandemic vaccines. The recipient
will be expected to assist partner countries
[[Page 46258]]
to plan, implement, and evaluate vaccination programs for influenza and
COVID-19.
Amount of Award: $47,000,000 in Federal Fiscal Year (FFY) 2021
funds, and an estimated total of $100,000,000 over the five-year period
of performance, subject to availability of funds.
Period of Performance: September 30, 2021 through September 29,
2026.
Authority: Section 307 of the Public Health Service Act, as amended
(42 U.S.C. 242l).
Dated: August 12, 2021.
Joseph I. Hungate III,
Deputy Director, Office of Financial Resources, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-17678 Filed 8-17-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 18, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.